TickerFacts.

Arvinas, Inc. (ARVN): Share Repurchases

Annual figures by period end, from SEC filings.

$91.90M
Year ended 2025-12-31
2023-12-31: $02024-12-31: $02025-12-31: $91.90M$91.90M
2023-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$91.90Mn/a2026-02-24, From 2025-01-01
2024-12-31$0n/a2026-02-24, From 2024-01-01
2023-12-31$0n/a2026-02-24, From 2023-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Arvinas, Inc. (ARVN)2025-12-31$91.90Mn/a
Ligand Pharmaceuticals Inc (LGND)2025-12-31$15.00Mn/a
Keros Therapeutics, Inc. (KROS)2025-12-31$375.00Mn/a
Anaptysbio, Inc (ANAB)2025-12-31$68.63Mn/m
Lifevantage Corp (LFVN)2026-06-30$2.04M-35.1%
Cryoport, Inc. (CYRX)2025-12-31$10.01Mn/a
Innoviva, Inc. (INVA)2025-12-31$4.53M-69.3%
Nature's Sunshine Products Inc (NATR)2025-12-31$16.31M+84.1%
BridgeBio Pharma, Inc. (BBIO)2025-12-31$48.28Mn/a

Compare ARVN, LGND, KROS, ANAB side by side · Screen every company in Pharmaceutical Preparations ↗